219 related articles for article (PubMed ID: 33507594)
1. Luteolin, inflammation and cancer: Special emphasis on gut microbiota.
Franza L; Carusi V; Nucera E; Pandolfi F
Biofactors; 2021 Mar; 47(2):181-189. PubMed ID: 33507594
[TBL] [Abstract][Full Text] [Related]
2. Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti-inflammatory activity, and the gut microbiota-liver-brain axis.
Daily JW; Kang S; Park S
Biofactors; 2021 Mar; 47(2):218-231. PubMed ID: 33347668
[TBL] [Abstract][Full Text] [Related]
3. Luteolin, a flavonoid with potential for cancer prevention and therapy.
Lin Y; Shi R; Wang X; Shen HM
Curr Cancer Drug Targets; 2008 Nov; 8(7):634-46. PubMed ID: 18991571
[TBL] [Abstract][Full Text] [Related]
4. From nature to therapy: Luteolin's potential as an immune system modulator in inflammatory disorders.
Hussain MS; Gupta G; Goyal A; Thapa R; Almalki WH; Kazmi I; Alzarea SI; Fuloria S; Meenakshi DU; Jakhmola V; Pandey M; Singh SK; Dua K
J Biochem Mol Toxicol; 2023 Nov; 37(11):e23482. PubMed ID: 37530602
[TBL] [Abstract][Full Text] [Related]
5. Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression.
Rezai-Zadeh K; Ehrhart J; Bai Y; Sanberg PR; Bickford P; Tan J; Shytle RD
J Neuroinflammation; 2008 Sep; 5():41. PubMed ID: 18817573
[TBL] [Abstract][Full Text] [Related]
6. Antitumor Effect and Gut Microbiota Modulation by Quercetin, Luteolin, and Xanthohumol in a Rat Model for Colorectal Cancer Prevention.
Pérez-Valero Á; Magadán-Corpas P; Ye S; Serna-Diestro J; Sordon S; Huszcza E; Popłoński J; Villar CJ; Lombó F
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674851
[TBL] [Abstract][Full Text] [Related]
7. Luteolin as a modulator of skin aging and inflammation.
Gendrisch F; Esser PR; Schempp CM; Wölfle U
Biofactors; 2021 Mar; 47(2):170-180. PubMed ID: 33368702
[TBL] [Abstract][Full Text] [Related]
8. Application of Luteolin in Neoplasms and Nonneoplastic Diseases.
Rakoczy K; Kaczor J; Sołtyk A; Szymańska N; Stecko J; Sleziak J; Kulbacka J; Baczyńska D
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958980
[TBL] [Abstract][Full Text] [Related]
9. Luteolin suppresses the JAK/STAT pathway in a cellular model of intestinal inflammation.
Nunes C; Almeida L; Barbosa RM; Laranjinha J
Food Funct; 2017 Jan; 8(1):387-396. PubMed ID: 28067377
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of Luteolin in the Greek Flora, Isolation of Luteolin and Its Action for the Treatment of Periodontal Diseases.
Arampatzis AS; Pampori A; Droutsa E; Laskari M; Karakostas P; Tsalikis L; Barmpalexis P; Dordas C; Assimopoulou AN
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067450
[TBL] [Abstract][Full Text] [Related]
11. Multi-Faceted Role of Luteolin in Cancer Metastasis: EMT, Angiogenesis, ECM Degradation and Apoptosis.
Rocchetti MT; Bellanti F; Zadorozhna M; Fiocco D; Mangieri D
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240168
[TBL] [Abstract][Full Text] [Related]
12. Distribution and biological activities of the flavonoid luteolin.
López-Lázaro M
Mini Rev Med Chem; 2009 Jan; 9(1):31-59. PubMed ID: 19149659
[TBL] [Abstract][Full Text] [Related]
13. Immunopharmacological Activities of Luteolin in Chronic Diseases.
Huang L; Kim MY; Cho JY
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768462
[TBL] [Abstract][Full Text] [Related]
14. Effect of Luteolin and Apigenin on the Production of Il-31 and Il-33 in Lipopolysaccharides-Activated Microglia Cells and Their Mechanism of Action.
Che DN; Cho BO; Kim JS; Shin JY; Kang HJ; Jang SI
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32204450
[TBL] [Abstract][Full Text] [Related]
15. Powerful anti-inflammatory action of luteolin: Potential increase with IL-38.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Pandolfi F
Biofactors; 2021 Mar; 47(2):165-169. PubMed ID: 33755250
[TBL] [Abstract][Full Text] [Related]
16. Anti-Inflammatory and Active Biological Properties of the Plant-Derived Bioactive Compounds Luteolin and Luteolin 7-Glucoside.
Caporali S; De Stefano A; Calabrese C; Giovannelli A; Pieri M; Savini I; Tesauro M; Bernardini S; Minieri M; Terrinoni A
Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334812
[TBL] [Abstract][Full Text] [Related]
17. Targeting cell signaling and apoptotic pathways by luteolin: cardioprotective role in rat cardiomyocytes following ischemia/reperfusion.
Xu T; Li D; Jiang D
Nutrients; 2012 Dec; 4(12):2008-19. PubMed ID: 23235403
[TBL] [Abstract][Full Text] [Related]
18. Luteolin Alters Macrophage Polarization to Inhibit Inflammation.
Wang S; Cao M; Xu S; Shi J; Mao X; Yao X; Liu C
Inflammation; 2020 Feb; 43(1):95-108. PubMed ID: 31673976
[TBL] [Abstract][Full Text] [Related]
19. A network pharmacology strategy to investigate the anti-inflammatory mechanism of luteolin combined with in vitro transcriptomics and proteomics.
Huang XF; Zhang JL; Huang DP; Huang AS; Huang HT; Liu Q; Liu XH; Liao HL
Int Immunopharmacol; 2020 Sep; 86():106727. PubMed ID: 32593158
[TBL] [Abstract][Full Text] [Related]
20. Luteolin: Nature's promising warrior against Alzheimer's and Parkinson's disease.
Goyal A; Solanki K; Verma A
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23619. PubMed ID: 38091364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
